Paper25136604
Disruption of HPV16-E7 by CRISPR/Cas system induces apoptosis and growth inhibition in HPV16 positive human cervical cancer cells.
Hu Z and 13 others. Biomed Res Int, 2014. Cited by 167 papers, by iCite.
Cite this record
ConductScience Library. Disruption of HPV16-E7 by CRISPR/Cas system induces apoptosis and growth inhibition in HPV16 positive human cervical cancer cells. Papers, record 25136604. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25136604
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Disruption of HPV16-E7 by CRISPR/Cas system induces apoptosis and growth inhibition in HPV16 positive human cervical cancer cells.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| CRISPR-Cas Systems | Major topic |
| Cell Proliferation | Major topic |
| Papillomavirus E7 Proteins | Major topic |
| Uterine Cervical Neoplasms | Major topic |
| Apoptosis | |
| Female | |
| HEK293 Cells | |
| Human papillomavirus 16 | |
| Humans |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT03057912 | A Safety and Efficacy Study of TALEN and CRISPR/Cas9 in the Treatment of HPV-related Cervical Intraepithelial NeoplasiaⅠ | Background |
Source ClinicalTrials.gov
References19
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20331326 | Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types. | J Manag Care Pharm | 2010 | https://conductscience.org/library/papers/20331326 | PubMed |
| 2 | 19861444 | Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications. | Clin Cancer Res | 2009 | https://conductscience.org/library/papers/19861444 | PubMed |
| 3 | 20680825 | The generation of zinc finger proteins by modular assembly. | Methods Mol Biol | 2010 | https://conductscience.org/library/papers/20680825 | PubMed |
| 4 | 17379808 | CRISPR provides acquired resistance against viruses in prokaryotes. | Science | 2007 | https://conductscience.org/library/papers/17379808 | PubMed |
| 5 | 23979578 | Targeted heritable mutation and gene conversion by Cas9-CRISPR in Caenorhabditis elegans. | Genetics | 2013 | https://conductscience.org/library/papers/23979578 | PubMed |
| 6 | 19470664 | Targeted genome editing in human cells with zinc finger nucleases constructed via modular assembly. | Genome Res | 2009 | https://conductscience.org/library/papers/19470664 | PubMed |
| 7 | 12083799 | Induction of senescence-like state and suppression of telomerase activity through inhibition of HPV E6/E7 gene expression in cells immortalized by HPV16 DNA. | Exp Cell Res | 2002 | https://conductscience.org/library/papers/12083799 | PubMed |
| 8 | 12044010 | Papillomaviruses and cancer: from basic studies to clinical application. | Nat Rev Cancer | 2002 | https://conductscience.org/library/papers/12044010 | PubMed |
| 9 | 23287722 | RNA-guided human genome engineering via Cas9. | Science | 2013 | https://conductscience.org/library/papers/23287722 | PubMed |
| 10 | 23992846 | Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. | Cell | 2013 | https://conductscience.org/library/papers/23992846 | PubMed |
| 11 | 23360964 | Efficient genome editing in zebrafish using a CRISPR-Cas system. | Nat Biotechnol | 2013 | https://conductscience.org/library/papers/23360964 | PubMed |
| 12 | 12897142 | Pathways of DNA double-strand break repair during the mammalian cell cycle. | Mol Cell Biol | 2003 | https://conductscience.org/library/papers/12897142 | PubMed |
| 13 | 19158789 | The promises and pitfalls of RNA-interference-based therapeutics. | Nature | 2009 | https://conductscience.org/library/papers/19158789 | PubMed |
| 14 | 23471067 | RNA guides genome engineering. | Nat Biotechnol | 2013 | https://conductscience.org/library/papers/23471067 | PubMed |
| 15 | 23792628 | High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. | Nat Biotechnol | 2013 | https://conductscience.org/library/papers/23792628 | PubMed |
| 16 | 18755502 | Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention in a mouse model of cervical cancer. | Gynecol Oncol | 2008 | https://conductscience.org/library/papers/18755502 | PubMed |
| 17 | 12727893 | Non-homologous end joining as an important mutagenic process in cell cycle-arrested cells. | EMBO J | 2003 | https://conductscience.org/library/papers/12727893 | PubMed |
| 18 | 12208848 | Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation. | Genes Dev | 2002 | https://conductscience.org/library/papers/12208848 | PubMed |
| 19 | 12556961 | Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. | Br J Cancer | 2003 | https://conductscience.org/library/papers/12556961 | PubMed |
Cited by121
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 167 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42819744 | Advances in immunotherapy for HPV-associated malignancies: emerging strategies and clinical progress. | Front Immunol | 2026 | https://conductscience.org/library/papers/42819744 | PubMed |
| 42554845 | CRISPR/Cas system as a novel therapeutic strategy to combat multi-drug-resistant bacteria. | Arch Microbiol | 2026 | https://conductscience.org/library/papers/42554845 | PubMed |
| 42493737 | Advancing Antiviral Design: Integrating Natural Products, Computation and Targeted Delivery. | Chem Biol Drug Des | 2026 | https://conductscience.org/library/papers/42493737 | PubMed |
| 42328613 | Role of CRISPR-Cas system as a new approach in fighting the antimicrobial resistance of bacterial and viral pathogens. | Infect Dis Immun | 2025 | https://conductscience.org/library/papers/42328613 | PubMed |
| 42277467 | Innovative strategies to overcome cancer drug resistance: from nanodelivery systems to targeted therapeutics. | Discov Oncol | 2026 | https://conductscience.org/library/papers/42277467 | PubMed |
| 41596696 | In Silico Design and Characterization of a Rationally Engineered Cas12j2 Gene Editing System for the Treatment of HPV-Associated Cancers. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41596696 | PubMed |
| 41476860 | Therapeutic applications of CRISPR-Cas9 gene editing. | Front Genome Ed | 2025 | https://conductscience.org/library/papers/41476860 | PubMed |
| 41420181 | HPV-driven inflammatory pathways in ovarian carcinogenesis: molecular mechanisms and emerging therapeutic interventions. | J Ovarian Res | 2025 | https://conductscience.org/library/papers/41420181 | PubMed |
| 41304764 | Targeted Drug Delivery Strategies in Overcoming Antimicrobial Resistance: Advances and Future Directions. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/41304764 | PubMed |
| 41284414 | CRISPR Technology: Transforming the Future of Medicine and Diagnostics. | Biochemistry | 2025 | https://conductscience.org/library/papers/41284414 | PubMed |
| 41171314 | CRISPR-based gene therapy for huntington's disease: current advances and future prospects. | Neurogenetics | 2025 | https://conductscience.org/library/papers/41171314 | PubMed |
| 41020881 | Emerging Therapeutic Strategies for HPV-Related Cancers: From Gene Editing to Precision Oncology. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/41020881 | PubMed |
| 40943604 | Disruption of Human Papillomavirus 16 E6/E7 Genes Using All-in-One Adenovirus Vectors Expressing Eight Double-Nicking Guide RNAs. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40943604 | PubMed |
| 40831701 | Towards the elimination of infectious HPV: exploiting CRISPR/Cas innovations. | Front Cell Infect Microbiol | 2025 | https://conductscience.org/library/papers/40831701 | PubMed |
| 40400023 | HPV-driven cancers: a looming threat and the potential of CRISPR/Cas9 for targeted therapy. | Virol J | 2025 | https://conductscience.org/library/papers/40400023 | PubMed |
| 40095096 | Revealing the viral culprits: the hidden role of the oral virome in head and neck cancers. | Arch Microbiol | 2025 | https://conductscience.org/library/papers/40095096 | PubMed |
| 39834176 | Research Status of Clustered Regulary Interspaced Short Palindromic Repeats Technology in the Treatment of Human Papillomavirus (HPV) Infection Related Diseases. | Cancer Control | 2025 | https://conductscience.org/library/papers/39834176 | PubMed |
| 39769084 | Expanding Horizons of CRISPR/Cas Technology: Clinical Advancements, Therapeutic Applications, and Challenges in Gene Therapy. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39769084 | PubMed |
| 39619730 | CRISPR-Cas Systems in the Fight Against Antimicrobial Resistance: Current Status, Potentials, and Future Directions. | Infect Drug Resist | 2024 | https://conductscience.org/library/papers/39619730 | PubMed |
| 39524822 | Emerging Gene-editing nano-therapeutics for Cancer. | Heliyon | 2024 | https://conductscience.org/library/papers/39524822 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ANXA5 | 308 | PubTator's text mining | https://conductscience.org/library/genes/308 | NCBI Gene |
| BCAR1 | 9564 | PubTator's text mining | https://conductscience.org/library/genes/9564 | NCBI Gene |
| FBN2 | 2201 | PubTator's text mining | https://conductscience.org/library/genes/2201 | NCBI Gene |
| GZF1 | 64412 | PubTator's text mining | https://conductscience.org/library/genes/64412 | NCBI Gene |
| POTEF | 728378 | PubTator's text mining | https://conductscience.org/library/genes/728378 | NCBI Gene |
| PRL | 5617 | PubTator's text mining | https://conductscience.org/library/genes/5617 | NCBI Gene |
| PTDSS1 | 9791 | PubTator's text mining | https://conductscience.org/library/genes/9791 | NCBI Gene |
| RB1 | 5925 | PubTator's text mining | https://conductscience.org/library/genes/5925 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25136604
GET https://conductscience.org/api/papers/v1/25136604/cited_by?page=2